Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.

September 12, 2008 updated by: AstraZeneca
Retrospective cohort study to evaluate the effect of the association of PPIs with NSAIDs in work leave time.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

6356

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Madrid, Spain
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Data base of patients with work leave due to a sprain of ankle

Description

Inclusion Criteria:

  • Work leave due to a sprain of ankle

Exclusion Criteria:

  • (none)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Patients with sprain of ankle treated with NSAID

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total work leave time
Time Frame: Jan 2007 to Dec 2007
Jan 2007 to Dec 2007

Secondary Outcome Measures

Outcome Measure
Time Frame
GI complications
Time Frame: Jan 2007 to Dec 2007
Jan 2007 to Dec 2007
Direct medical costs
Time Frame: Jan 2007 to Dec 2007
Jan 2007 to Dec 2007

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Collaborators

Ibermutuamur M.A.T.E.P.S

Investigators

  • Study Director: Javier N Rivero, MSc, Epidemiology Unit. AstraZeneca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Study Completion (ACTUAL)

August 1, 2008

Study Registration Dates

First Submitted

July 14, 2008

First Submitted That Met QC Criteria

July 15, 2008

First Posted (ESTIMATE)

July 16, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

September 15, 2008

Last Update Submitted That Met QC Criteria

September 12, 2008

Last Verified

July 1, 2008

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • NIS-GES-DUM-2008/3

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sprain of Ankle

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe